{
  "main_header": {
    "sid": 444125,
    "name": "Ishita Drugs",
    "stock_name": "Ishita Drugs",
    "full_name": "Ishita Drugs & Industries Ltd",
    "name_url": "stocks-analysis/ishita-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "72.26",
    "chg": -2.74,
    "chgp": "-3.65%",
    "dir": -1,
    "prev_price": "75.00",
    "mcapval": "21.61 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524400,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE806D01016",
    "curr_date": "Aug 12",
    "curr_time": "",
    "bse_nse_vol": "878 ",
    "exc_status": "Active",
    "traded_date": "Aug 12, 2026",
    "traded_date_str": "2026 08 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/ishita-drugs-444125-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ishita Drugs & Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ishita-drugs-industries-ltd-is-rated-sell-4002791",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IshitaDrugsIndu_mojoScore_4002791.png",
        "date": "2026-05-21 10:10:22",
        "description": "Ishita Drugs & Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 10,
    "sid": "444125",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/ishita-drugs-industries-444125"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "08-Aug-2026",
      "details": "Re-appointment of Mrs. Abha Agrawal (DIN: 01589479) as a Non -executive Non- Inependent Director of the Company post attaining the age of 75 years.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting Held On 08H August 2026",
      "datetime": "08-Aug-2026",
      "details": "Unaudited Financial Results of the Compmany for the quarter ended 30th June 2026 along with limited review report issued by statutory auditor.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th August 2026",
      "datetime": "08-Aug-2026",
      "details": "Outcome of the Board meeting held on 08th August 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ishita Drugs & Industries Ltd is Rated Sell

2026-05-21 10:10:22

Ishita Drugs & Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read More

View All News